-
1 Comment
Thalys Medical Technology Group Inc is currently in a long term downtrend where the price is trading 9.6% below its 200 day moving average.
From a valuation standpoint, the stock is 85.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.4.
Thalys Medical Technology Group Inc's total revenue rose by 25.0% to $585M since the same quarter in the previous year.
Its net income has dropped by 35.5% to $21M since the same quarter in the previous year.
Finally, its free cash flow fell by 2593.1% to $-102M since the same quarter in the previous year.
Based on the above factors, Thalys Medical Technology Group Inc gets an overall score of 2/5.
| Exchange | SHG |
|---|---|
| CurrencyCode | CNY |
| Sector | Healthcare |
| ISIN | CNE1000030C3 |
| Industry | Diagnostics & Research |
| PE Ratio | None |
|---|---|
| Market Cap | 2B |
| Target Price | None |
| Beta | 0.79 |
| Dividend Yield | None |
Thalys Medical Technology Group Corporation provides intensive operation services of medical inspection in China. The company was formerly known as Thalys Medical Technology Inc. and changed its name to Thalys Medical Technology Group Inc. in September 2020. Thalys Medical Technology Group Inc. was founded in 2004 and is headquartered in Wuhan, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 603716.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
